These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 14730505

  • 1. Vitamin D receptor and analogs.
    Dusso AS, Thadhani R, Slatopolsky E.
    Semin Nephrol; 2004 Jan; 24(1):10-6. PubMed ID: 14730505
    [Abstract] [Full Text] [Related]

  • 2. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar 01; 30(3):434-40. PubMed ID: 25324357
    [Abstract] [Full Text] [Related]

  • 6. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
    Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Tokumoto M, Gonzalez-Suarez I, Lu Y, Tominaga Y, Cannata-Andia J, Slatopolsky E, Dusso AS.
    J Am Soc Nephrol; 2008 Feb 01; 19(2):310-20. PubMed ID: 18216322
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D receptor ligand therapy in chronic kidney disease.
    Gonzalez E.
    Clin Nephrol; 2008 Oct 01; 70(4):271-83. PubMed ID: 18826852
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
    Sawada K, Wu-Wong JR, Chen YW, Wessale JL, Kanai G, Kakuta T, Fukagawa M.
    J Steroid Biochem Mol Biol; 2017 Mar 01; 167():48-54. PubMed ID: 27989797
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D and the parathyroid.
    Beckerman P, Silver J.
    Am J Med Sci; 1999 Jun 01; 317(6):363-9. PubMed ID: 10372835
    [Abstract] [Full Text] [Related]

  • 10. [Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure].
    Dusilová Sulková S.
    Vnitr Lek; 2012 Nov 01; 58(11):839-49. PubMed ID: 23256830
    [Abstract] [Full Text] [Related]

  • 11. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S, Zhang W, Mao J, Wang M, Ni L, Zhang M, Zhang Q, Chen J.
    J Nephrol; 2018 Dec 01; 31(6):941-951. PubMed ID: 30171599
    [Abstract] [Full Text] [Related]

  • 12. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P, Akerstrom G, Westin G.
    Eur J Endocrinol; 2002 Nov 01; 147(5):671-5. PubMed ID: 12444900
    [Abstract] [Full Text] [Related]

  • 13. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E, Finch J, Ritter C, Takahashi F.
    Am J Kidney Dis; 1998 Oct 01; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [Abstract] [Full Text] [Related]

  • 14. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T, Rastad J, Szabó E, Westin G, Akerström G.
    J Clin Endocrinol Metab; 2000 May 01; 85(5):2000-3. PubMed ID: 10843188
    [Abstract] [Full Text] [Related]

  • 15. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr 01; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D analogues for the management of secondary hyperparathyroidism.
    Martin KJ, González EA.
    Am J Kidney Dis; 2001 Nov 01; 38(5 Suppl 5):S34-40. PubMed ID: 11689385
    [Abstract] [Full Text] [Related]

  • 17. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T.
    Kidney Int; 2006 Aug 01; 70(3):486-95. PubMed ID: 16788697
    [Abstract] [Full Text] [Related]

  • 18. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K.
    J Am Soc Nephrol; 2002 Aug 01; 13(8):2110-6. PubMed ID: 12138143
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
    Naveh-Many T, Volovelsky O.
    Int J Mol Sci; 2020 Jun 18; 21(12):. PubMed ID: 32570711
    [Abstract] [Full Text] [Related]

  • 20. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr 18; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.